Abstract
Background Even though there have been inquiries into the survival rates of asphyxiated neonates in Africa, there is scarce data concerning the recovery duration for asphyxiated newborns in developing nations and the factors affecting this process. Consequently, the objective of this study is to ascertain the time it takes for asphyxiated neonates to recover and identify its predictors.
Methods Conducting a retrospective follow-up investigation, the study took place at Debre Berhan Comprehensive Specialized Hospital from January 1st, 2020 to December 31st 2022, involving a sample size of 330. The analysis included the computation of the Kaplan-Meier survival curve, the log-rank test, and the median time. Additionally, a multivariable Cox proportional hazard regression model was employed to determine the survival status.
Results in this study, among the 330 participants (100%), a total of 270(81.8%) successfully survived throughout the entire cohort. Predictors are independent of each other, affecting the time to recovery and survival of asphyxiated neonates, encompassed prolonged labor (AHR: 0.42, 95%CI:0.21-0.81), normal birth weight (AHR:2.21, 95% CI: 1.30-3.70),non-altered consciousness (AHR:2.52, CI:1.50-4.24), non-depressed moro reflex of the newborn (AHR:2.40, 95%CI: 1.03-5.61), stage I HIE (AHR: 5.11, 95% CI: 1.98-13.19), and direct oxygen administration via the nose (AHR: 4.18, 95% CI: 2.21-7.89).
Conclusion The duration for recovery seems to be slightly prolonged in comparison to other research findings. This underscores the significance of vigilant monitoring, early preventive interventions, and swift actions to avert the progression of infants to the most severe stage of HIE.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethical approval was obtained from Debre Berhan University, Asrat Woldeyes Health Science Campus Institutional Review Board before its commencement. In addition, an official letter of permission was obtained from Debre Berhan Compressive Specialized Hospital before the data collection begins. The data collectors gave the interviewees an explanation of the study's purpose, benefits, risks, discomfort, and right to withdraw or refuse at any time for any reason before the interview commenced. Before the interview began, the study participants were provided written consent. In addition, the privacy and confidentiality of participants were assured during the data collection. The individual's identity was not revealed, so the responses to the study were anonymous.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
all the relevant data contained in the manuscript
